Filed: 2/17/2026ACC: 0000950142-26-000395
📋 What this filing means
GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $2.87B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$2.87B
Total AUM (reported)
158.59M
Total Shares
Allocation by class
CL A$1.11B38.6%
COM$1.08B37.5%
COM SHS CL A$535.11M18.6%
ADS$153.00M5.3%
ORD SHS$394.8K0.0%
Portfolio Concentration
Top 3$1.57B54.5%
4–10$1.28B44.4%
11–25$29.58M1.0%
Top 3 weight
54.5%
Top 10 weight
99.0%
Voting Authority Distribution
Total shares with voting rights: 158.59M
Sole
Full voting authority
158.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
DLOCAL
SOLEShares46.66M
TypeSH
Market value$659.73M
22.97%
Sole
46.66M
Shared
0.00
None
0.00
CHIME
SOLEShares21.26M
TypeSH
Market value$535.11M
18.63%
Sole
21.26M
Shared
0.00
None
0.00
XP, INC
SOLEShares22.70M
TypeSH
Market value$371.58M
12.93%
Sole
22.70M
Shared
0.00
None
0.00
ALKAMI
SOLEShares11.99M
TypeSH
Market value$276.64M
9.63%
Sole
11.99M
Shared
0.00
None
0.00
ALIGNMENT HEALTHCARE
SOLEShares13.17M
TypeSH
Market value$260.06M
9.05%
Sole
13.17M
Shared
0.00
None
0.00
REVOLUTION MEDICINES
SOLEShares2.81M
TypeSH
Market value$224.05M
7.80%
Sole
2.81M
Shared
0.00
None
0.00
PHARVARIS
SOLEShares8.03M
TypeSH
Market value$222.87M
7.76%
Sole
8.03M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS
SOLEShares6.12M
TypeSH
Market value$153.00M
5.33%
Sole
6.12M
Shared
0.00
None
0.00
NURIX THERAPEUTICS
SOLEShares4.90M
TypeSH
Market value$92.90M
3.23%
Sole
4.90M
Shared
0.00
None
0.00
EUROPEAN WAX CENTER
SOLEShares13.11M
TypeSH
Market value$47.20M
1.64%
Sole
13.11M
Shared
0.00
None
0.00
RISKIFIED
SOLEShares5.32M
TypeSH
Market value$26.47M
0.92%
Sole
5.32M
Shared
0.00
None
0.00
GROVE COLLABORATIVE
SOLEShares2.47M
TypeSH
Market value$2.72M
0.09%
Sole
2.47M
Shared
0.00
None
0.00
WEBULL
SOLEShares50.82K
TypeSH
Market value$394.8K
0.01%
Sole
50.82K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DLOCALSOLE | CL A | 46.66M | SH | $659.73M 22.97% | 46.66M | 0.00 | 0.00 |
CHIMESOLE | COM SHS CL A | 21.26M | SH | $535.11M 18.63% | 21.26M | 0.00 | 0.00 |
XP, INCSOLE | CL A | 22.70M | SH | $371.58M 12.93% | 22.70M | 0.00 | 0.00 |
ALKAMISOLE | COM | 11.99M | SH | $276.64M 9.63% | 11.99M | 0.00 | 0.00 |
ALIGNMENT HEALTHCARESOLE | COM | 13.17M | SH | $260.06M 9.05% | 13.17M | 0.00 | 0.00 |
REVOLUTION MEDICINESSOLE | COM | 2.81M | SH | $224.05M 7.80% | 2.81M | 0.00 | 0.00 |
PHARVARISSOLE | COM | 8.03M | SH | $222.87M 7.76% | 8.03M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | ADS | 6.12M | SH | $153.00M 5.33% | 6.12M | 0.00 | 0.00 |
NURIX THERAPEUTICSSOLE | COM | 4.90M | SH | $92.90M 3.23% | 4.90M | 0.00 | 0.00 |
EUROPEAN WAX CENTERSOLE | CL A | 13.11M | SH | $47.20M 1.64% | 13.11M | 0.00 | 0.00 |
RISKIFIEDSOLE | CL A | 5.32M | SH | $26.47M 0.92% | 5.32M | 0.00 | 0.00 |
GROVE COLLABORATIVESOLE | CL A | 2.47M | SH | $2.72M 0.09% | 2.47M | 0.00 | 0.00 |
WEBULLSOLE | ORD SHS | 50.82K | SH | $394.8K 0.01% | 50.82K | 0.00 | 0.00 |